#BEGIN_DRUGCARD DB04414

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
Mo7O24

# Chemical_IUPAC_Name:
dodecakis($l^{3}-oxidanediidyl)dodecacyclo[7.5.1.1^{1,7}.1^{3,5}.1^{3,13}.1^{5,7}.0^{1,4}.0^{1,6}.0^{2,11}.0^{2,13}.0^{6,9}.0^{11,15}]heptamolybdoxane-1,1,1,1,1,1,3,3,3,3,3,3,5,5,5,5,5,5,7,7,7,7,7,7,9,9,9,9,9,9,11,11,11,11,11,11,13,13,13,13,13,13-dotetracontakis(ylium)-2,2,4,4,6,6,8,8,10,10,12,12,14,14,15,15,16,16,17,17,18,18,19,19-tetracosauide

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Heptamolybdate

# HET_ID:
MO7

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/7Mo.24O/q7*+6;24*-2

# InChI_Key:
InChIKey=RAJWDNGOYZCDTL-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4414

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
1055.57

# Molecular_Weight_Mono:
1069.21580585

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1P0Z

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0

# Predicted_LogS:
0

# Predicted_Water_Solubility:
Not Available

# Primary_Accession_No:
DB04414

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5288823

# PubChem_Substance_ID:
46505678

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02207

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[O--][Mo+6]123([O--])[O--][Mo+6]45([O--])([O--])[O--][Mo+6]67([O--])([O--])[O--][Mo+6]89([O--])([O--])[O--][Mo+6]%10%11([O--])([O--])[O--][Mo+6]%12([O--])([O--])([O--]1)[O--]%10[Mo+6]([O--]2)([O--]8)([O--]46)([O--]35%12)[O--]79%11

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:18 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cell inner membrane
multi-pass membrane protein (Probable)

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
U31464

# Drug_Target_1_GenBank_ID_Protein:
924991

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
citA

# Drug_Target_1_Gene_Sequence:
>1644 bp
ATGTCTATCTACCCAATGTATACCCGAAAAATCACCCACTGGTTTGCCAGGCGATCGTTT
CAGAATCGCATCTTCCTGCTGATCTTATTCACCTCGACGATCGTCATGCTGGCGATGTCA
TGGTATCTGACAGACATTACCGAGGAGCGTCTGCATTATCAGGTCGGGCAACGGGCGCTG
ATTCAGGCGATGCAGATTTCGGCGATGCCGGAGCTGGTGGAGGCAGTGCAGAAACGCGAT
CTCGCCAGAATCAAAGCCCTTATCGACCCCATGCGTTCGTTCTCCGACGCCACCTACATC
ACCGTCGGTGATGCCAGCGGCCAGCGCCTCTATCACGTCAATCCTGATGAAATCGGCAAA
TCGATGGAAGGCGGCGATAGCGATGAGGCGTTGATAAACGCTAAAAGCTACGTGTCAGTG
CGCAAAGGCTCGCTGGGATCGTCGCTGCGCGGTAAATCGCCGATTCAGGACGCAACCGGC
AAGGTGATCGGCATTGTGTCGGTAGGCTATACCATTGAGCAACTGGAAAACTGGCTCAGC
CTGCAGATAAGTTCGCTGCTGATCCCGATGGCCATCATGTTACTGCTTCTGCTCTTTTGC
GCCCGCCGCTTCTCACTGCATATCAAAAAACAGATGCTCAATATGGAACCCCAGCAGCTG
TCACAGCTGTTGATCCAGCAAAGCGTGCTGTTTGAATCGGTGTTCGAAGGGCTTATCGCC
ATCGACTCCGATTATAAAATCACTGCGATTAATCAGACTGCGCGTCGCCTGCTCAATTTG
AGTCAGCCGGAACCGACGCTTATCGGCAAACGGATCAGCAGCGTTATCTCGCAGGAGGTC
TTCTTCTACGATGCGCCACAGACCAATAAAAAAGACGAGATCGTTACCTTCAATCAGATC
AAAGTGATCGCCAGCCGGATGGCGGTGATCTTAAACAATGAGCCACAGGGCTGGGTGATC
AGCTTTCGCAGCAAAGACGATATCAACACCCTTAGCCTGCAGCTTAGCCAGGTACAACAA
TATGCCGATAACCTGCGCGCCGTACAGCATGAGCATCGCAATCTGATCTCCACTATCGCC
GGTCTGCTGTTTCTTAAACGCTATAACCAAGCGCTGGAACTTATCCAACAGCAGTCGGAA
AGTCACCAGAAGGTGATCGATTTTATTGCACGCAATTTCCAGGACAACCACCTGGCCGGG
CTGTTGATCGGCAAATATTACCGGGCCAAAGAGCTTGGACTTGAGCTGATTTTCGATCCG
GCCTGCTTCGTTGATAGATTACCTACCGCCCTTTCGCACAACGAATGGATCTCGATCGTG
GGGAATCTACTTGATAACGCCTACAATGCCAGCCTGCGTCAACCGCAGGGTTCAAAACAG
ATCGAATGCCTGATCAACAGTGATGGCCAGGAGGTGATCATTGAGATCGCCGACCAGGGA
TGCGGCATTGACGAGGCGCTGCGCGATCGGATCTTCGAGCGCGGCGTCACCAGCAGCGCC
AGCAAAGATCATGGTATCGGACTCTGGCTAGTACGCAGCTACGTGGAACAAGCAGGCGGC
AGTATCGTCGTCGAAAATAATATTCCTTTTGGCACCATTTTTACGCTTTATATCCCCCTG
ACCCGAGATGAACATCATGGATAG

# Drug_Target_1_General_Function:
Signal transduction mechanisms

# Drug_Target_1_General_References:
10447894	Kaspar S, Perozzo R, Reinelt S, Meyer M, Pfister K, Scapozza L, Bott M: The periplasmic domain of the histidine autokinase CitA functions as a highly specific citrate receptor. Mol Microbiol. 1999 Aug;33(4):858-72.
8748036	Bott M, Meyer M, Dimroth P: Regulation of anaerobic citrate metabolism in Klebsiella pneumoniae. Mol Microbiol. 1995 Nov;18(3):533-46.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3539

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
61781

# Drug_Target_1_Name:
Sensor kinase citA

# Drug_Target_1_Number_of_Residues:
547

# Drug_Target_1_PDB_ID:
1P0Z

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02518	HATPase_c

# Drug_Target_1_Protein_Sequence:
>Sensor kinase citA
MSIYPMYTRKITHWFARRSFQNRIFLLILFTSTIVMLAMSWYLTDITEERLHYQVGQRAL
IQAMQISAMPELVEAVQKRDLARIKALIDPMRSFSDATYITVGDASGQRLYHVNPDEIGK
SMEGGDSDEALINAKSYVSVRKGSLGSSLRGKSPIQDATGKVIGIVSVGYTIEQLENWLS
LQISSLLIPMAIMLLLLLFCARRFSLHIKKQMLNMEPQQLSQLLIQQSVLFESVFEGLIA
IDSDYKITAINQTARRLLNLSQPEPTLIGKRISSVISQEVFFYDAPQTNKKDEIVTFNQI
KVIASRMAVILNNEPQGWVISFRSKDDINTLSLQLSQVQQYADNLRAVQHEHRNLISTIA
GLLFLKRYNQALELIQQQSESHQKVIDFIARNFQDNHLAGLLIGKYYRAKELGLELIFDP
ACFVDRLPTALSHNEWISIVGNLLDNAYNASLRQPQGSKQIECLINSDGQEVIIEIADQG
CGIDEALRDRIFERGVTSSASKDHGIGLWLVRSYVEQAGGSIVVENNIPFGTIFTLYIPL
TRDEHHG

# Drug_Target_1_Reaction:
ATP + protein L-histidine = ADP + protein N-phospho-L-histidine

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Member of the two-component regulatory system citA/citB. Probably activates citB by phosphorylation. The periplasmic domain binds H-citrate(2-), which is essential for induction of the citrate-fermentation genes

# Drug_Target_1_SwissProt_ID:
P52687

# Drug_Target_1_SwissProt_Name:
CITA_KLEPN

# Drug_Target_1_Synonyms:
EC 2.7.13.3

# Drug_Target_1_Theoretical_pI:
6.80

# Drug_Target_1_Transmembrane_Regions:
24-44
181-201

#END_DRUGCARD DB04414
